Daniel A. Kracov, JD
March 9, 2015 | Conquering the Cancer Care Continuum – Series Three: First Issue
Confusion over the rules governing drug compounding has been an issue for many years. However, concerns about the safety and quality of compounded sterile products (CSPs), spurred by an outbreak of fungal meningitis infections that occurred in October 2012, have led to a fundamental change in the regulatory framework.
Last modified: June 6, 2018